Risk and Severity of COPD Is Associated with the Group-Specific Component of Serum Globulin 1F Allele

Chest

Volumn 125, Issue 1, 2004, Pages 63-70

  Ito, Isao ^a   Nagai, Sonoko ^a   Hoshino, Yuma ^a   Muro, Shigeo ^a   Hirai, Toyohiro ^a   Tsukino, Mitsuhiro ^a   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Gc globulin; High resolution CT; Low attenuation area percentage; Mean CT score; Polymorphism; Vitamin D binding protein

Indexed keywords

SERUM GLOBULIN; SERUM GLOBULIN 1F; UNCLASSIFIED DRUG;

AGED; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE ENVIRONMENT INTERACTION; HOMOZYGOTE; HUMAN; INTERMETHOD COMPARISON; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POOR GENERAL CONDITION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SAMPLE SIZE;

EID: 1642575352     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.1.63     Document Type: Article

References (34)

1. Snider GL. Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis. Annu Rev Med 1989; 40:411-429
2. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1:1645-1648
3. Tager I, Tishler PV, Rosner B, et al. Studies of the familial aggregation of chronic bronchitis and obstructive airways disease. Int J Epidemiol 1978; 7:55-62
4. Khoury MJ, Beaty TH, Newill CA, et al. Genetic-environmental interactions in chronic airways obstruction. Int J Epidemiol 1986; 15:65-72
5. Higgins M, Keller J. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. J Chronic Dis 1975; 28:239-251
6. Kueppers F, Miller RD, Gordon H, et al. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 1977; 63:336-342
7. Cooke NE, Haddad JG. Vitamin D binding protein (Gc-globulin). Endocr Rev 1989; 10:294-307
8. 3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci U S A 1991; 88:8539-8543
9. Kew RR, Webster RO. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. J Clin Invest 1988; 82:364-369
10. Cooke NE, Willard HF, David EV, et al. Direct regional assignment of the gene for vitamin D binding protein (Gc-globulin) to human chromosome 4q11-q13 and identification of an associated DNA polymorphism. Hum Genet 1986; 73:225-229
11. Cleve H, Constans J. The mutants of the vitamin-D-binding protein: more than 120 variants of the Gc/DBP system. Vox Sang 1988; 54:215-225
12. Schellenberg D, Pare PD, Weir TD, et al. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med 1998; 157:957-961
13. Kueppers F, Miller RD, Gordon H, et al. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 1977; 63:336-342
14. Kauffmann F, Kleisbauer JP, Cambon-de-Mouzon A, et al. Genetic markers in chronic airflow limitation: a genetic epidemiologic study. Am Rev Respir Dis 1983; 127:263-269
15. Home SL, Cockcroft DW, Dosman JA. Possible protective effect against chronic obstructive airways disease by the Gc2 allele. Hum Hered 1990; 40:173-176
16. Ishii T, Keicho N, Teramoto S, et al. Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur Respir J 2001; 18:753-757
17. Gaensslen RE, Bell SC, Lee HC. Distributions of genetic markers in United States populations: III. Serum group systems and hemoglobin variants. J Forensic Sci 1987; 32: 1754-1774
18. Ishimoto G, Kuwata M, Nakajima H. Group-specific component (Gc) polymorphism in Japanese: an analysis by isoelectric focusing on polyacrylamide gels. Jpn J Hum Genet 1979; 24:75-83
19. Hoshino Y, Nagai S, Koyania H, et al. Airflow limitation in Japanese smokers: significance of serum neutrophil elastase/α(1)-proteinase inhibitor ratio and FEV(1) (%pred) adjusted by pack-years. Respiration 2000; 67:372-377
20. Sandford AJ, Chagani T, Weir TD, et al. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 2001; 163:469-473
21. Sakai N, Mishima M, Nishimura K, et al. An automated method to assess the distribution of low attenuation areas on chest CT scans in chronic pulmonary emphysema patients. Chest 1994; 106:1319-1325
22. Mishima M, Hirai T, Itoh H, et al. Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A 1999; 96:8829-8834
23. Mishima M, Oku Y, Kawakami K, et al. Quantitative assessment of the spatial distribution of low attenuation areas on X-ray CT using texture analysis in patients with chronic pulmonary emphysema. Front Med Biol Eng 1997; 8:19-34
24. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:877-8121
25. Braun A, Kofler A, Morawietz S, et al. Sequence and organization of the human vitamin D-binding protein gene. Biochim Biophys Acta 1993; 1216:385-394
26. Japan Society of Chest Diseases. The predicted values of pulmonary function testing in Japanese [appendix]. Jpn J Thorac Dis 1993; 31
27. Fletcher C, Peto R, Tinker C, et al. Factors related to the development of airflow obstruction. In: Fletcher C, Peto R, Tinker C, et al, eds. The natural history of chronic bronchitis and emphysema. London, UK: Oxford University Press, 1976; 70-105
28. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276
29. Madison R, Mittman C, Afifi AA, et al. Risk factors for obstructive lung disease. Am Rev Respir Dis 1981; 124:149-153
30. Beaty TH, Menkes HA, Cohen BH, et al. Risk factors associated with longitudinal change in pulmonary function. Am Rev Respir Dis 1984; 129:660-667
31. 1rantitrypsin deficiency: a longitudinal lung function study. N Z Med J 1981; 94:407-410
32. Nakano Y, Sakai H, Muro S, et al. Comparison of low attenuation areas on computed tomographic scans between inner and outer segments of the lung in patients with chronic obstructive pulmonary disease: incidence and contribution to lung function. Thorax 1999; 54:384-389
33. Sakao S, Tatsumi K, Igari H, et al. Association of tumor necrosis factor-α gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. Chest 2002; 122:416-420
34. White P, Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000; 11:320-327